Pivotal study about efficiency and safety of JTEC-01 made from revertant mosaicism in epidermolysis bullosa
Not Applicable
- Conditions
- recessive dystrophic epidermolysis bullosa or junctional epidermolysis bullosa
- Registration Number
- JPRN-UMIN000020734
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
(1)patients who have allergy to particular antibiotics (Penicillin, Kanamycin, Amphotericin B) . (2)patients who have allergy to caw, mouse or pig. (3)patients who participate in other clinical trials within 6 month. (4)patients who have malignant tumor or past history of malignancy within 3years (except cutaneous malignancy). (5)those who are pregnant or nursing mum, or patients who are planning pregnancy during the study. (6)patients whom the investigators judge inappropriate as a subject for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the individual rate of epithelialization (%) at 4 week after the graft
- Secondary Outcome Measures
Name Time Method